NCT06324682 ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing
| NCT ID | NCT06324682 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital of Ferrara |
| Condition | Arrhythmias, Cardiac |
| Study Type | OBSERVATIONAL |
| Enrollment | 8,400 participants |
| Start Date | 2023-01-01 |
| Primary Completion | 2033-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 8,400 participants in total. It began in 2023-01-01 with a primary completion date of 2033-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to evaluate the clinical characteristics of patients undergoing permanent cardiac pacing and to compare procedural efficacy and safety of different implantation approaches in the clinical practice of the participating centres. The contribution of non-fluoroscopic anatomical and electrophysiological reconstruction systems to device implantation procedures will also be evaluated. Participants \[patients over 18 years old with an indication to receive a definitive pacemaker/intracardiac defibrillator implant\] will receive a permanent cardiac pacing implant as requested according to European Society of Cardiology (ESC) guidelines; the investigators will evaluate procedural efficacy and safety of different implantation approaches.
Eligibility Criteria
Inclusion Criteria: * Indication for cardiac stimulation * Having performed the implantation of a device for cardiac stimulation Exclusion Criteria: * Age \< 18 years; * Pregnancy status;
Contact & Investigator
Matteo Bertini, MD, PhD
PRINCIPAL INVESTIGATOR
Azienda Ospedaliero Universitaria di Ferrara
Frequently Asked Questions
Who can join the NCT06324682 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Arrhythmias, Cardiac. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06324682 currently recruiting?
Yes, NCT06324682 is actively recruiting participants. Contact the research team at brtmtt2@unife.it for enrollment information.
Where is the NCT06324682 trial being conducted?
This trial is being conducted at Ferrara, Italy, Arezzo, Italy, Bologna, Italy, Bologna, Italy and 11 additional locations.
Who is sponsoring the NCT06324682 clinical trial?
NCT06324682 is sponsored by University Hospital of Ferrara. The principal investigator is Matteo Bertini, MD, PhD at Azienda Ospedaliero Universitaria di Ferrara. The trial plans to enroll 8,400 participants.